000 03097nam a22003495i 4500
999 _c80377
_d80377
001 80377
003 ES-MaUEC
005 20230208145636.0
007 cr nn 008mamaa
008 131121s2014 gw | s |||| 0|eng d
020 _a9783319023595
024 7 _a10.1007/978-3-319-02359-5
_2doi
040 _dES-MaUEC
050 4 _aRJ506.H9
_bS234 2014
100 1 _aSadek, Joseph
_0Local
_988495
245 1 2 _aA Clinician’s Guide to ADHD
_cby Joseph Sadek
250 _a2nd ed. 2014.
260 _aCham, Switzerland
_bSpringer International Publishing
_c2014
300 _a1 recurso en línea (XV, 118 p.)
_b7 ilustraciones, 2 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aIntroduction -- History of Attention Deficit Hyperactivity Disorder -- Epidemiology and Etiology of ADHD -- Impairment in Patients with ADHD -- How to Diagnose ADHD in Children and Adolescents -- How to Diagnose ADHD in Adults -- Differential Diagnosis -- ADHD Comorbidities -- ADHD and Driving -- Pharmacological Management of ADHD -- Management of Adverse Events -- Psychosocial Treatment of ADHD -- Follow-up of Patient with ADHD -- List of scales: children -- List of scales: Adults -- Snap Scale: Children -- Weiss functional impairment scale -- Weiss parent reporting -- Weiss self report -- Adult ADHD self-report scale -- Personal adversity questionnaire -- Personality difficulties questionnaire -- Diagnostic interview for ADHD in adults (diva).
520 _aThe Clinicianâ€{u3807}uide to ADHD combines the useful diagnostic and treatment approaches advocated in different guidelines with insights from other sources, including recent literature reviews and web resources. The aim is to provide clinicians with clear, concise, and reliable advice on how to approach this complex disorder. The guidelines referred to in compiling the book derive from authoritative sources in different regions of the world, including the United States, Canada, Australia, and Europe. After introductory discussion of epidemiology and etiology, guidance is provided on diagnosis in different age groups, differential diagnosis, assessment for potential comorbidities, and the issue of ADHD and driving. Advice is then given on the appropriate use of pharmacological and psychosocial treatment, the management of adverse events, and follow-up. A series of relevant scales, questionnaires, and websites are also included.
650 7 _aTrastornos por déficit de atención con hiperactividad
_2embne
_9157068
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-02359-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12881302
_b10-10-17
_c11-11-15
942 _2lcc
_cLE
945 _aRJ506.H9 S234 2014 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11561129
_z06-04-17
988 _aEBSPRINGER
998 _am
_a_alco
_a_vill
_b11-11-15
_cm
_dz
_e-
_feng
_ggw
_h2